General advice on methodology for such studies exist [112,117–119] and an assessment of how they have been implemented in the case of point of care testing strategies for active tuberculosis[120] and for interferon-gamma release assays for latent TB infection[121] have been published. Here, IFNG is linked to tuberculosis.